Live Webinar

A Look at PBM Reform and Transparency: Payer, Provider and Patient Impact

Hosted by AJMC, Managed Healthcare Executive, Pharmacy Times and PBMI

-- Days : -- HRS : -- MIN : -- SEC
Register Now →
Logo Image
  • News
  • Watch
  • Journals
  • Conferences
  • Events
  • Resources
  • CE
  • About AJMC
  • Subscribe
Opinion|Videos|November 8, 2024

From Guidelines to Practice: Advancing Lupus Nephritis Treatment

Amit Saxena, MD, discusses how evidence-based guidelines from ACR and KDIGO have evolved to shape lupus nephritis treatment approaches, emphasizing their critical role in standardizing patient care and incorporating recent advances like new therapeutic options and refined diagnostic criteria.

Episodes in this series

Video content above is prompted by the following:

  • In your view, why are guidelines for lupus nephritis important to patient care?
  • What role do the American College of Rheumatology (ACR) and Kidney Disease Improving Global Outcomes (KDIGO) guidelines play in shaping treatment practices for lupus nephritis?
  • What are some of the most significant recent changes in lupus nephritis guidelines?
  • How has the treatment approach for lupus nephritis evolved in recent years alongside these guidelines?

Related Content